dercum's disease - HEALTHY
pix11: Caliway Received U.S. FDA Fast Track Designation for CBL-514 for the Treatment of Dercum's Disease - Fast Track designation indicates CBL-514's potential in filling the unmet medical need of Dercum's disease. - CBL-514 is the first drug to receive Fast Track designation for Dercum's disease ...
Context Explanation
Caliway Received U.S. FDA Fast Track Designation for CBL-514 for the Treatment of Dercum's Disease WGNO: Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum's Disease Treatment - CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment. - CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum's ... Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum's Disease Treatment FOX40 News: Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum's Disease at World Orphan Drug Congress USA 2025 Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum's Disease at World Orphan Drug Congress USA 2025